These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 23707147)

  • 21. [SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].
    Tang B; Wang D; Xia J
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):819-22. PubMed ID: 9772474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6.
    Jacobi H; Schaprian T; Beyersmann J; Tezenas du Montcel S; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2022 Mar; 9(3):286-295. PubMed ID: 35188716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
    Rezende TJR; Adanyaguh I; Barsottini OGP; Bender B; Cendes F; Coutinho L; Deistung A; Dogan I; Durr A; Fernandez-Ruiz J; Göricke SL; Grisoli M; Hernandez-Castillo CR; Lenglet C; Mariotti C; Martinez ARM; Massuyama BK; Mochel F; Nanetti L; Nigri A; Ono SE; Öz G; Pedroso JL; Reetz K; Synofzik M; Teive H; Thomopoulos SI; Thompson PM; Timmann D; van de Warrenburg BPC; van Gaalen J; França MC; Harding IH
    J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):682-690. PubMed ID: 38383154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
    Wüllner U; Reimold M; Abele M; Bürk K; Minnerop M; Dohmen BM; Machulla HJ; Bares R; Klockgether T
    Arch Neurol; 2005 Aug; 62(8):1280-5. PubMed ID: 16087769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinico-genetic study of type I spinocerebelllar ataxia].
    Svetel M; Culjković B; Sternić N; Dragasević B; Stojković I; Romac S; Kostić VS
    Srp Arh Celok Lek; 1999; 127(5-6):157-62. PubMed ID: 10500422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in sleep stage R scoring in patients with autosomal dominant spinocerebellar ataxias (SCA1, SCA2 and SCA3) and oculomotor abnormalities: a whole night polysomnographic evaluation.
    Seshagiri DV; Sasidharan A; Kumar G; Pal PK; Jain S; Kutty BM; Yadav R
    Sleep Med; 2018 Feb; 42():97-102. PubMed ID: 29458753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
    Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
    Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stance instability in preclinical SCA1 mutation carriers: A 4-year prospective posturography study.
    Nanetti L; Alpini D; Mattei V; Castaldo A; Mongelli A; Brenna G; Gellera C; Mariotti C
    Gait Posture; 2017 Sep; 57():11-14. PubMed ID: 28551466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
    Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G
    Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
    Petit E; Schmitz-Hübsch T; Coarelli G; Jacobi H; Heinzmann A; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Pulst SM; Subramony SH; Ewenczyk C; Brice A; Durr A; Klockgether T; Ashizawa T; Tezenas du Montcel S
    J Neurol; 2024 Jul; 271(7):3743-3753. PubMed ID: 38822840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.
    Gan SR; Wang J; Figueroa KP; Pulst SM; Tomishon D; Lee D; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():492. PubMed ID: 29057148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonia and ataxia progression in spinocerebellar ataxias.
    Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.
    Linnemann C; Tezenas du Montcel S; Rakowicz M; Schmitz-Hübsch T; Szymanski S; Berciano J; van de Warrenburg BP; Pedersen K; Depondt C; Rola R; Klockgether T; García A; Mutlu G; Schöls L
    Cerebellum; 2016 Apr; 15(2):165-73. PubMed ID: 26054379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CAG trinucleotide mutation detection in patients with hereditary spinocerebellar ataxia].
    Tang B; Xia J; Wang D; Tang X; Shen L; Liu C; Dai H; Yan X; Pan Q; Xiao J; Zhang B; Ou Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):281-4. PubMed ID: 10514531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.